ResearcherXijing HospitalNo recent work listed
Zhengcai Liu
Matched on ORCID iD 0000-0001-5046-440X; OpenAlex author ID A5038385267.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 2
2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 3
- LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway. Co-author DOI 10.1038/s41417-020-00213-4↗
- Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer. Last author DOI 10.2217/epi-2018-0051↗
- Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. Co-author DOI 10.1159/000453186↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Shibin Qu · 3 shared papers, 2016–2021
- Paper LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway. DOI 10.1038/s41417-020-00213-4↗
- Paper Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer. DOI 10.2217/epi-2018-0051↗
- Paper Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. DOI 10.1159/000453186↗
- Haimin Li · 3 shared papers, 2016–2021
- Paper LINC00671 suppresses cell proliferation and metastasis in pancreatic cancer by inhibiting AKT and ERK signaling pathway. DOI 10.1038/s41417-020-00213-4↗
- Paper Circular RNA circRHOT1 is upregulated and promotes cell proliferation and invasion in pancreatic cancer. DOI 10.2217/epi-2018-0051↗
- Paper Circular RNA Expression Profile of Pancreatic Ductal Adenocarcinoma Revealed by Microarray. DOI 10.1159/000453186↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.